Todd Brown, MD, PhD | Johns Hopkins University Baltimore-India Clinical Trials Unit

Todd Brown, MD, PhD

CRS:

Role:

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu

Committees

Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
Protocol Vice-Chair, ACTG 5280, ACTG 5303
Co-chair, ACTG 5361s
Co-investigator, ACTG 5257

Leadership Committees

BWI CTU Leadership Committee

CRS

Roles

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More